William Roland Mann serves as Executive at NeuBase Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, William Roland Mann has executed 2 insider transactions totaling $36.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 30, 2022 involved purchasing 6,200 shares valued at $11.9K.
William Roland Mann currently holds 11,200 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Roland Mann has been a net buyer of NBSE stock. They have purchased $36.9K and sold $0 worth of shares.
William Roland Mann's most recent insider trade was on Mar 30, 2022, when they purchased 6,200 shares at $1.92 per share.
Get notified when new Form 4 filings are submitted
| $5.00 |
| Discretionary |